Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,330 | 41 | 96.9% |
| Education | $42.39 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aerie Pharmaceuticals, Inc. | $233.96 | 3 | $0 (2019) |
| Horizon Therapeutics plc | $188.98 | 4 | $0 (2023) |
| Omeros Corporation | $186.09 | 5 | $0 (2019) |
| ANI Pharmaceuticals, Inc. | $182.19 | 7 | $0 (2023) |
| TOPCON MEDICAL SYSTEMS, INC. | $131.44 | 1 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $126.19 | 8 | $0 (2020) |
| Allergan, Inc. | $70.24 | 4 | $0 (2020) |
| AbbVie, Inc. | $63.25 | 3 | $0 (2018) |
| Carl Zeiss Meditec, Inc. | $55.89 | 1 | $0 (2018) |
| Mallinckrodt LLC | $42.39 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $247.07 | 8 | ANI Pharmaceuticals, Inc. ($182.19) |
| 2022 | $49.73 | 1 | Horizon Therapeutics plc ($49.73) |
| 2020 | $160.46 | 7 | Horizon Therapeutics plc ($74.37) |
| 2019 | $396.45 | 12 | Omeros Corporation ($186.09) |
| 2018 | $272.21 | 8 | Aerie Pharmaceuticals, Inc. ($131.13) |
| 2017 | $246.53 | 8 | TOPCON MEDICAL SYSTEMS, INC. ($131.44) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 08/31/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $70.02 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 06/30/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 04/28/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 03/27/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 03/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $64.88 | General |
| Category: TEPEZZA | ||||||
| 01/05/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 01/05/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 02/14/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $49.73 | General |
| Category: TEPEZZA | ||||||
| 12/03/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/03/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/31/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: TEPEZZA | ||||||
| 08/25/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/09/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/12/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/11/2020 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $60.09 | General |
| 12/05/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $6.40 | General |
| Category: Ophthalmology | ||||||
| 10/30/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Ophthalmology | ||||||
| 10/29/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Ophthalmology | ||||||
| 08/20/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/17/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | CRYSTALENS (Device) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/06/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $102.83 | General |
| Category: Glaucoma | ||||||
| 05/20/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), LOTEMAX | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/06/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $25.75 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 7 | 176 | 180 | $36,114 | $9,535 |
| 2020 | 11 | 802 | 896 | $166,882 | $59,668 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 33 | $9,273 | $3,192 | 34.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 32 | 32 | $7,744 | $1,608 | 20.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,355 | $1,454 | 27.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 29 | 30 | $5,070 | $1,342 | 26.5% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 22 | 23 | $2,990 | $857.01 | 28.7% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 17 | 17 | $2,686 | $541.63 | 20.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 27 | 28 | $2,996 | $540.10 | 18.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 118 | 118 | $34,146 | $13,650 | 40.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 167 | 182 | $36,544 | $13,583 | 37.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 112 | 128 | $35,937 | $13,243 | 36.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 98 | 117 | $15,741 | $5,626 | 35.7% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2020 | 107 | 130 | $16,025 | $5,207 | 32.5% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 64 | 73 | $9,585 | $2,500 | 26.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 34 | $5,491 | $1,914 | 34.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 64 | 68 | $6,815 | $1,781 | 26.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 19 | 19 | $4,577 | $1,520 | 33.2% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 11 | 11 | $1,221 | $340.53 | 27.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 16 | $800.00 | $303.39 | 37.9% |
About Dr. Mitchell Wolin, MD
Dr. Mitchell Wolin, MD is a Ophthalmology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457342867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Wolin, MD has received a total of $1,372 in payments from pharmaceutical and medical device companies, with $247.07 received in 2023. These payments were reported across 44 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,330).
As a Medicare-enrolled provider, Wolin has provided services to 978 Medicare beneficiaries, totaling 1,076 services with total Medicare billing of $69,203. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Greenville, SC
- Active Since 11/03/2005
- Last Updated 02/18/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457342867
Products in Payments
- Rhopressa (Drug) $233.96
- PURIFIED CORTROPHIN GEL (Drug) $182.19
- OCT-MAESTRO (Device) $131.44
- TEPEZZA (Drug) $128.89
- OMIDRIA (Drug) $117.63
- PROLENSA (Drug) $79.03
- LUMIGAN (Drug) $70.24
- Omidria (Drug) $68.46
- OPMI Lumera (Device) $55.89
- Humira (Biological) $48.12
- ACTHAR (Biological) $42.39
- CRYSTALENS (Device) $22.41
- Tecnis Multifocal Family of 1-piece IOLS (Device) $22.04
- XELPROS (Drug) $20.21
- LOTEMAX GEL (Drug) $18.88
- SOFPORT AO (Device) $16.32
- Tecnis 1-piece IOL (Device) $14.38
- BESIVANCE (Drug) $12.60
- VYZULTA (Drug) $12.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Greenville
Alan Leahey, Md, MD
Ophthalmology — Payments: $35,694
Dr. William Ballinger, M.d, M.D
Ophthalmology — Payments: $10,552
Dr. Douglas Stokes, M.d, M.D
Ophthalmology — Payments: $5,909
Brian Welcome, M.d, M.D
Ophthalmology — Payments: $5,885
Brian Shelley, M.d, M.D
Ophthalmology — Payments: $5,443
Dr. Ann Ostrovsky, M.d, M.D
Ophthalmology — Payments: $4,797